Literature DB >> 15208260

Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease.

Bryan Maloney1, Yuan-Wen Ge, Nigel Greig, Debomoy K Lahiri.   

Abstract

Potentially toxic amyloid beta-peptide (Abeta) in Alzheimer's disease (AD) is generated from a family of Abeta-containing precursor proteins (APP), which is regulated via the 5'-untranslated region (5'-UTR) of its mRNA. We analyzed 5'-UTRs of the APP superfamily, including amyloid plaque-forming and non-amyloid plaque-forming species, and of prions (27 different DNA sequences). A "CAGA" sequence proximal to the "ATG" start codon was present in a location unique to APP genes of amyloid plaque-forming species and absent in all other genes surveyed. This CAGA box is immediately upstream of an interleukin-1-responsive element (acute box). In addition, the proximal CAGA box is predicted to appear on a stem-loop structure in both human and guinea pig APP mRNA. This stem-loop is part of a predicted bulge-loop that encompasses a known iron regulatory element (IRE). Electrophoretic mobility shift with segments of the APP 5'-UTR showed that a region with the proximal CAGA sequence binds nuclear proteins, and this UTR fragment is active in a reporter gene functional assay. Thus, the 5'-UTR in the human APP but not those of APP-like proteins contains a specific region that may participate in APP regulation and may determine a more general model for amyloid generation as seen in AD. The 5'-UTR of human APP contains several interesting control elements, such as an acute box element, a CAGA box, an IRE, and a transforming growth factor-beta-responsive element, that could control APP expression and provide suitable and specific drug targets for AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208260     DOI: 10.1096/fj.03-1703fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Biochem Biophys Res Commun       Date:  2010-12-21       Impact factor: 3.575

2.  Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells.

Authors:  Debomoy K Lahiri; Bryan Maloney; Yuan-Wen Ge
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

Authors:  Jack T Rogers; Sohan Mikkilineni; Ippolita Cantuti-Castelvetri; Deborah H Smith; Xudong Huang; Sanghamitra Bandyopadhyay; Catherine M Cahill; Maria L Maccecchini; Debomoy K Lahiri; Nigel H Greig
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

5.  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 6.  Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging.

Authors:  Caleb E Finch; Steven N Austad
Journal:  Age (Dordr)       Date:  2012-01-05

Review 7.  Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

8.  Down-regulation of APLP1 mRNA expression in hippocampus of pilocarpine-induced epileptic rats.

Authors:  Cheng Wang; Zi-Li You; Ding-Ding Zhang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

9.  Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis.

Authors:  Brian Brock; Riyaz Basha; Katie DiPalma; Amy Anderson; G Jean Harry; Deborah C Rice; Bryan Maloney; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Alzheimers Dis       Date:  2008-02       Impact factor: 4.472

10.  Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine.

Authors:  Amelia Marutle; Masao Ohmitsu; Mats Nilbratt; Nigel H Greig; Agneta Nordberg; Kiminobu Sugaya
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.